Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L36 pseudogene 17** (RPL36P17) is a processed pseudogene related to the functional ribosomal protein L36 gene (RPL36). Unlike the parental RPL36 gene, which encodes a protein component of the large 60S ribosomal subunit involved in protein synthesis, pseudogenes such as RPL36P17 do not encode functional proteins due to disabling mutations or regulatory changes. RPL36P17 has no established role as a receptor, enzyme, transporter, or therapeutic target. Like most ribosomal protein pseudogenes, it is not known to have direct biological functions, disease associations, or drug interactions[6][9]. The existence of numerous ribosomal protein pseudogenes in the genome results from retrotransposition events, and these elements are typically considered non-functional[6]. **Notes on completeness/ambiguity:** - RPL36P17 is a pseudogene, not an active receptor or target, nor is it generally considered biologically functional or relevant for therapy. - There is no evidence for a role in disease, drug interactions, or relevance as a biomarker. - Searching key biomedical and genomic resources yields only confirmation of its pseudogene status and no additional molecular or pathophysiological detail[9]. - If biological or pathophysiological function is needed, use the parental protein: **Ribosomal protein L36** (RPL36), not the pseudogene[1][3]. If you require information on the functional ribosomal protein L36 instead, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 17 (RPL36P17).